Health Utilities of Bilateral Severe-to-Profound Hearing Loss with Assistive Devices

Yi-Wen Chen1,2, Pei-Hsuan Lin3, Te-Yung Fang4,5

  • 1Department of Pharmacy, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.

PubMed

Insights

This study measured health utilities for children with severe hearing loss using assistive devices. Bilateral cochlear implants showed the highest utility, offering crucial data for health technology assessments.

Area of Science:

  • Audiology
  • Health Economics
  • Pediatrics

Background:

  • Congenital hearing loss affects newborns, impacting auditory and speech development.
  • Early intervention with assistive devices is crucial for improving outcomes in children.
  • Quantifying health utilities associated with different assistive devices is essential for informed decision-making.

Purpose of the Study:

  • To measure and compare the health utilities of children with bilateral severe-to-profound hearing impairment using various assistive devices.
  • To provide data for cost-utility analyses and health technology assessments.

Main Methods:

  • Developed descriptions of four hypothetical health states: no devices, bilateral hearing aids, bimodal hearing, and bilateral cochlear implants.
  • Collected utility values from 37 healthcare professionals using the Visual Analogue Scale (VAS) and Time Trade-Off (TTO) methods.
  • Analyzed utility scores to determine significant differences between health states.

Main Results:

  • Mean VAS utility scores: 0.31 (no devices), 0.41 (hearing aids), 0.63 (bimodal), 0.82 (cochlear implants).
  • Mean TTO utility scores: 0.60 (no devices), 0.69 (hearing aids), 0.81 (bimodal), 0.90 (cochlear implants).
  • Statistically significant differences (p < 0.05) were found between all pairwise comparisons of health states for both VAS and TTO.

Conclusions:

  • This study successfully elicited health utility values for different assistive devices in pediatric bilateral hearing impairment.
  • The obtained utility data are critical for future cost-utility analyses and health technology assessments.
  • Assistive devices significantly improve health utility, with bilateral cochlear implants demonstrating the highest value.